1. Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity. (19th April 2021) Authors: Ineichen, B. V.; Moridi, T.; Ewing, E.; Ouellette, R.; Manouchehrinia, A.; Stawiarz, L.; Ferreira, D.; Muehlboeck, S. J.; Kuhle, J.; Westman, E.; Leppert, D.; Hillert, J.; Olsson, T.; Kockum, I.; Piehl, F.; Granberg, T. Journal: Journal of internal medicine Issue: Volume 290:Number 2(2021) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis. (7th November 2020) Authors: Raftopoulos, R.; Kuhle, J.; Grant, D.; Hickman, S. J.; Altmann, D. R.; Leppert, D.; Blennow, K.; Zetterberg, H.; Kapoor, R.; Giovannoni, G.; Gnanapavan, S. Journal: European journal of neurology Issue: Volume 28:Number 2(2021) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗